Skip to main content

EGFR Resisters and LCRF Research Partnership: First Study Grant Awarded!

*December 2021*

Our first $150,000 LCRF grant awarded to Yang Tian, PhD from the Icahn School of Medicine at Mount Sinai. Her project is titled, “Targeting lung lineage plasticity to suppress Osimertinib-induced drug-tolerant persisters. Please view the announcement of this lung cancer study video here.